Korro Bio, Inc. Stock Analysis & AI Score
Korro Bio, Inc. (KRRO) has an ST Score of 36.3 (C), driven by its Growth (B+) and held back by its Momentum (F). Analysts rate it Buy with a $15.00 price target (+56.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Korro Bio, Inc. (KRRO) has an ST Score of 36.3 (C), driven by its Growth (B+) and held back by its Momentum (F). Analysts rate it Buy with a $15.00 price target (+56.7% upside).
- Strongest
- GrowthB+
- Weakest
- MomentumF
All factor grades
- GrowthB+
- ForecastB
- Financial StrengthB-
- ProfitabilityD+
- ValuationD
- MomentumF
- Piotroski2/9
Contact
KRRO stock: frequently asked questions
What is KRRO's ST Score?
Korro Bio, Inc. (KRRO) has an ST Score of 36.3 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is KRRO a buy, hold, or sell?
Analysts rate KRRO a Buy, with a price target of $15.00 (+56.7% vs the current price). Our ST Score grades it C (36.3/100). The ST Score is a data-driven signal, not a recommendation.
What are KRRO's factor grades?
Valuation D, Profitability D+, Financial Strength B-, Momentum F, Growth B+, Forecast B.
What is KRRO's valuation grade?
Korro Bio, Inc. (KRRO) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is KRRO's growth grade?
Korro Bio, Inc. (KRRO) earns a growth grade of B+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is KRRO's profitability grade?
Korro Bio, Inc. (KRRO) earns a profitability grade of D+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is KRRO's financial strength grade?
Korro Bio, Inc. (KRRO) earns a financial strength grade of B-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for KRRO?
The average analyst price target for Korro Bio, Inc. (KRRO) is $15.00 from 12 analysts, which is +56.7% versus the recent price of $9.57.
What is KRRO's Piotroski score?
Korro Bio, Inc. (KRRO) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.